Cancer Research Horizons
Alternate names Cancer Research UK Technology, Cancer Research UK Commercial
Parent institution Cancer Research UK
ROR: Yes
Works count: 283
Citations count: 25,160
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
2018 · Robert J. Motzer, Nizar M. Tannir, et al. · New England Journal of Medicine
Overview of the main outcomes in breast-cancer prevention trials
2003 · Jack Cuzick, T.J. Powles, et al. · The Lancet
Progress in cancer survival, mortality, and incidence in seven high-income countries 1995–2014 (ICBP SURVMARK-2): a population-based study
2019 · Melina Arnold, Mark J. Rutherford, et al. · The Lancet Oncology